Laurus Labs shares were trading firm in early trades. The stock touched 52-week high today and is currently trading 1.2 percent higher.

Biocon Limited, a leader in biopharmaceuticals, captured investor attention today by trading within Rs 336.05 to Rs 355.45.

Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong fundamentals and sectoral potential.

Sharekhan reiterates its BUY recommendation for Ipca Laboratories, revising the target price to Rs 1,765.

KRChoksey Research reiterates its BUY recommendation for Balaji Amines Ltd with a revised target price of Rs 2,328, reflecting a potential upside of 16.6% from the current market price of Rs 1,996.

Biocon Ltd, a leading biopharmaceutical company, has been given an "Accumulate" rating by Geojit Financial Services with a target price of Rs. 376.